Reams G P, Bauer J H
Am J Kidney Dis. 1986 May;7(5):402-6. doi: 10.1016/s0272-6386(86)80089-0.
Twenty-seven subjects with essential hypertension were prospectively followed for a minimum of 100 weeks, receiving either enalapril monotherapy or enalapril and hydrochlorothiazide combination therapy. Blood pressure and the renin-angiotensin-aldosterone system were assessed following 4 weeks of placebo therapy, and 56 and 96 weeks of maintenance drug therapy. Blood pressure was well controlled with either form of therapy. Plasma renin activity remained stimulated following both long-term monotherapy and combination therapy. However, immunoreactive plasma angiotensin II concentration was not suppressed following either long-term monotherapy or combination therapy. Similarly, plasma aldosterone concentration was not suppressed following either form of therapy; indeed, combination therapy was associated with stimulation of plasma aldosterone concentration. We conclude that enalapril monotherapy or enalapril/hydrochlorothiazide therapy was effective in controlling blood pressure, but that long-term blood pressure control must be related to an angiotensin II independent antihypertensive mechanism.
对27名原发性高血压患者进行了至少100周的前瞻性随访,这些患者接受依那普利单药治疗或依那普利与氢氯噻嗪联合治疗。在安慰剂治疗4周以及维持药物治疗56周和96周后,对血压和肾素 - 血管紧张素 - 醛固酮系统进行了评估。两种治疗方式均能很好地控制血压。长期单药治疗和联合治疗后,血浆肾素活性均持续受到刺激。然而,长期单药治疗或联合治疗后,免疫反应性血浆血管紧张素II浓度均未被抑制。同样,两种治疗方式下血浆醛固酮浓度均未被抑制;事实上,联合治疗与血浆醛固酮浓度升高有关。我们得出结论,依那普利单药治疗或依那普利/氢氯噻嗪治疗在控制血压方面是有效的,但长期血压控制一定与不依赖血管紧张素II的降压机制有关。